Cargando…
Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies characterized by variable but most often indolent biologic behavior. Well-differentiated NETs can be broadly classified as either carcinoid or pancreatic NET. Although they have similar characteristics on routine histologic evalu...
Autores principales: | Chan, Jennifer, Kulke, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147239/ https://www.ncbi.nlm.nih.gov/pubmed/25092520 http://dx.doi.org/10.1007/s11864-014-0294-4 |
Ejemplares similares
-
Targeted Therapy in Biliary Tract Cancers
por: Merla, Amartej, et al.
Publicado: (2015) -
Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
por: Ter‐Minassian, Monica, et al.
Publicado: (2017) -
Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas
por: Dasari, Arvind, et al.
Publicado: (2022) -
Current Challenge: Endoscopic Submucosal Dissection of Superficial Non-ampullary Duodenal Epithelial Tumors
por: Akahoshi, Kazuya, et al.
Publicado: (2020) -
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis
por: Sonbol, Mohamad Bassam, et al.
Publicado: (2022)